Sponsored BOFAS 2025 Registration for best BEOFAA Fellow Sponsored BOFAS 2025 Registration for best BEOFAA Fellow BOFAS is excited to collaborate with BEOFAA and welcomes the best BEOFAA fellow to our 2025 Annual Congress in Brighton. Click for more details. 31 August 2024 Read more
BOFAS 2025 Registration Open BOFAS 2025 Registration Open Visit our webpage to register! 08 July 2024 https://www.bofas.org.uk/annual-meeting/registration Read more
BOA Annual Congress Abstract Submissions BOA Annual Congress Abstract Submissions Submissions Close on Sunday 5th! 30 April 2024 BOA Annual Congress Abstract Submission Read more
10Feb2026 BOFAS Principles Course Liverpool 2026 - space available 10/02/2026 - 11/02/2026 Read more These courses are aimed at Higher Surgical Trainees / ST3 onwards and are designed to teach the core of Foot and Ankle surgery in an informal and interactive environment. The emphasis is on clinical examination cases, discussion groups and typical day-to-day clinic scenarios. Although not an exam preparation course, content is taught to the standard expected in the FRCS(Tr & Orth) exam; that of a day-one non-specialist orthopaedic consultant. Applications will open now. Read more
Togay Koç / 11 July 2022 / Categories: Abstracts, 2016, Podium Foot and ankle injections - are they worth it? D. Marsland, J. Grice, J. Calder Introduction: Injections are used to treat a wide variety of pathologies. Our aim was to evaluate the efficacy and safety of foot and ankle injections in our clinic. Materials and methods: We performed a retrospective review of notes and a telephone questionnaire audit into the clinical outcome of all patients who underwent an injection of the foot or ankle in a year. All procedures were performed in an out-patient setting by a consultant musculoskeletal radiologist using either ultrasound or X-ray guidance, with a minimum of two year follow-up. According to the pathology treated, the type of injection included depomedrone, hyaluronic acid and high volume saline injections. Results: Overall 410/446 (92%) patients reported a significant improvement in symptoms and 227 (62%) reported complete resolution of their pain, with 127 (28%) remaining asymptomatic at two year follow-up. The mode time of recurrence of pain was three months. 59 (13%) underwent a further injection and 102 (23%) underwent operative intervention within the follow-up period. There were no reported infections. Complications occurred in two percent of patients, including steroid flare, pain and plantar plate ruptures. Conclusion: Injections are a safe and effective option for treating a variety of foot and ankle conditions and reduce the need for surgery. They are particularly effective for the treatment of ankle soft tissue impingement. They appear ineffective in providing significant improvement in pain for longer than three months in conditions such as plantar fasciitis and hallux rigidus. Print 849 Tags: AnkleHallux RigidusPlantar Fasciitis